Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today reported financial results for the first quarter ended March 31, 2023.
“Our first quarter results were in-line with our expectations and we are reaffirming our full year 2023 outlook,” said Brian Millard, Vice President and Chief Financial Officer of Universal Display Corporation. “While macro uncertainties continue to linger, we believe that recent OLED investment and product announcements pave the path for a new OLED adoption cycle and strong growth in the coming years. Additionally, today we announced the acquisition of Merck KGaA, Darmstadt, Germany’s phosphorescent emitter patent portfolio, which further strengthens our leadership position in the OLED ecosystem and broadens the tools available to our team as we develop new and next-generation phosphorescent materials. We also announced a new multi-year collaboration agreement with Merck KGaA, Darmstadt, Germany.”
Financial Highlights for the First Quarter of 2023
- Total revenue in the first quarter of 2023 was $130.5 million as compared to $150.5 million in the first quarter of 2022. As we have previously noted, the near-term weakness in the overall global market economy continues to have an impact on forecasted demand for OLED products utilizing our emitter material over the remaining life of several customers’ contracts compared to prior estimates, resulting in us recording a positive cumulative catch-up adjustment to total revenue during the first quarter of 2023 of $5.7 million arising from changes in estimates of transaction price.
- Revenue from material sales was $70.2 million in the first quarter of 2023 as compared to $86.7 million in the first quarter of 2022. This decrease was primarily the result of lower unit material volume.
- Revenue from royalty and license fees was $55.2 million in the first quarter of 2023 as compared to $59.8 million in the first quarter of 2022. This decrease was primarily the result of lower unit material volume.
- Cost of material sales was $29.5 million in the first quarter of 2023 as compared to $29.9 million in the first quarter of 2022. Cost of material sales during the quarter decreased due to lower unit material volume, offset by a $3.3 million increase in our inventory provision and $4.7 million in costs related to our Shannon facility, which commenced manufacturing activities in June 2022.
- Total gross margin was 75% in the first three months of 2023 as compared to 78% in the first three months of 2022. Shannon facility costs of $4.7 million and the inventory provision of $3.3 million in 2023 contributed to a 6% decrease in total gross margin between periods.
- Operating income was $45.4 million in the first quarter of 2023 as compared to $62.3 million in the first quarter of 2022.
- Net income was $39.8 million or $0.83 per diluted share in the first quarter of 2023 as compared to $50.0 million or $1.05 per diluted share in the first quarter of 2022.
Revenue Comparison
|
($ in thousands)
|
|
Three Months Ended March 31,
|
|
|
|
|
2023
|
|
|
2022
|
|
|
Material sales
|
|
$
|
70,190
|
|
|
$
|
86,691
|
|
|
Royalty and license fees
|
|
|
55,210
|
|
|
|
59,802
|
|
|
Contract research services
|
|
|
5,067
|
|
|
|
3,977
|
|
|
Total revenue
|
|
$
|
130,467
|
|
|
$
|
150,470
|
|
Cost of Materials Comparison
|
($ in thousands)
|
|
Three Months Ended March 31,
|
|
|
|
|
2023
|
|
|
2022
|
|
|
Material sales
|
|
$
|
70,190
|
|
|
$
|
86,691
|
|
|
Cost of material sales
|
|
|
29,488
|
|
|
|
29,920
|
|
|
Gross margin on material sales
|
|
|
40,702
|
|
|
|
56,771
|
|
|
Gross margin as a % of material sales
|
|
|
58
|
%
|
|
|
65
|
%
|
2023 Guidance
The Company affirms its previous revenue guidance and believes that 2023 revenue will be the range of $550 million to $600 million.
Dividend
The Company also announced a second quarter cash dividend of $0.35 per share on the Company’s common stock. The dividend is payable on June 30, 2023 to all shareholders of record on June 16, 2023.
Conference Call Information
In conjunction with this release, Universal Display will host a conference call on Wednesday, May 3, 2023 at 5:00 p.m. Eastern Time. The live webcast of the conference call can be accessed under the events page of the Company's Investor Relations website at ir.oled.com. Those wishing to participate in the live call should dial 1-877-524-8416 (toll-free) or 1-412-902-1028. Please dial in 5-10 minutes prior to the scheduled conference call time. An online archive of the webcast will be available within two hours of the conclusion of the call.
About Universal Display Corporation
Universal Display Corporation (Nasdaq: OLED) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. Founded in 1994 and with subsidiaries and offices around the world, the Company currently owns, exclusively licenses or has the sole right to sublicense more than 5,500 patents issued and pending worldwide. Universal Display licenses its proprietary technologies, including its breakthrough high-efficiency UniversalPHOLED® phosphorescent OLED technology that can enable the development of energy-efficient and eco-friendly displays and solid-state lighting. The Company also develops and offers high-quality, state-of-the-art UniversalPHOLED materials that are recognized as key ingredients in the fabrication of OLEDs with peak performance. In addition, Universal Display delivers innovative and customized solutions to its clients and partners through technology transfer, collaborative technology development and on-site training. To learn more about Universal Display Corporation, please visit https://oled.com/.
Universal Display Corporation and the Universal Display Corporation logo are trademarks or registered trademarks of Universal Display Corporation. All other company, brand or product names may be trademarks or registered trademarks.
All statements in this document that are not historical, such as those relating to the projected adoption, development and advancement of the Company’s technologies, and the Company’s expected results, as well as the growth of the OLED market and the Company’s opportunities in that market, are forward-looking financial statements within the meaning of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on any forward-looking statements in this document, as they reflect Universal Display Corporation’s current views with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated. These risks and uncertainties are discussed in greater detail in Universal Display Corporation’s periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, including, in particular, the section entitled “Risk Factors” in Universal Display Corporation’s Annual Report on Form 10-K for the year ended December 31, 2022. Universal Display Corporation disclaims any obligation to update any forward-looking statement contained in this document.
Follow Universal Display Corporation
Twitter
Facebook
YouTube
(OLED-C)
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(in thousands, except share and per share data)
|
|
|
March 31, 2023
|
|
|
December 31, 2022
|
|
|
ASSETS
|
|
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
158,294
|
|
|
$
|
93,430
|
|
|
Short-term investments
|
|
|
487,812
|
|
|
|
484,345
|
|
|
Accounts receivable
|
|
|
92,677
|
|
|
|
92,664
|
|
|
Inventory
|
|
|
174,245
|
|
|
|
183,220
|
|
|
Other current assets
|
|
|
37,193
|
|
|
|
45,791
|
|
|
Total current assets
|
|
|
950,221
|
|
|
|
899,450
|
|
|
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $123,388 and $117,118
|
|
|
145,281
|
|
|
|
143,445
|
|
|
ACQUIRED TECHNOLOGY, net of accumulated amortization of $174,820 and $189,671
|
|
|
35,843
|
|
|
|
38,382
|
|
|
OTHER INTANGIBLE ASSETS, net of accumulated amortization of $9,341 and $8,989
|
|
|
7,947
|
|
|
|
8,247
|
|
|
GOODWILL
|
|
|
15,535
|
|
|
|
15,535
|
|
|
INVESTMENTS
|
|
|
213,369
|
|
|
|
259,861
|
|
|
DEFERRED INCOME TAXES
|
|
|
63,292
|
|
|
|
58,161
|
|
|
OTHER ASSETS
|
|
|
104,224
|
|
|
|
109,739
|
|
|
TOTAL ASSETS
|
|
$
|
1,535,712
|
|
|
$
|
1,532,820
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
9,741
|
|
|
$
|
9,519
|
|
|
Accrued expenses
|
|
|
25,346
|
|
|
|
51,002
|
|
|
Deferred revenue
|
|
|
37,419
|
|
|
|
45,599
|
|
|
Other current liabilities
|
|
|
42,451
|
|
|
|
29,577
|
|
|
Total current liabilities
|
|
|
114,957
|
|
|
|
135,697
|
|
|
DEFERRED REVENUE
|
|
|
17,843
|
|
|
|
18,279
|
|
|
RETIREMENT PLAN BENEFIT LIABILITY
|
|
|
60,248
|
|
|
|
59,790
|
|
|
OTHER LIABILITIES
|
|
|
43,199
|
|
|
|
43,685
|
|
|
Total liabilities
|
|
|
236,247
|
|
|
|
257,451
|
|
|
SHAREHOLDERS’ EQUITY:
|
|
|
|
|
|
|
|
Preferred Stock, par value $0.01 per share, 5,000,000 shares authorized, 200,000
shares of Series A Nonconvertible Preferred Stock issued and outstanding
(liquidation value of $7.50 per share or $1,500)
|
|
|
2
|
|
|
|
2
|
|
|
Common Stock, par value $0.01 per share, 200,000,000 shares authorized, 48,697,467
and 49,136,030 shares issued, and 47,331,819 and 47,770,382 shares outstanding, at
March 31, 2023 and December 31, 2022, respectively
|
|
|
487
|
|
|
|
491
|
|
|
Additional paid-in capital
|
|
|
679,390
|
|
|
|
681,335
|
|
|
Retained earnings
|
|
|
676,347
|
|
|
|
653,277
|
|
|
Accumulated other comprehensive loss
|
|
|
(15,477
|
)
|
|
|
(18,452
|
)
|
|
Treasury stock, at cost (1,365,648 shares at March 31, 2023 and December 31, 2022)
|
|
|
(41,284
|
)
|
|
|
(41,284
|
)
|
|
Total shareholders’ equity
|
|
|
1,299,465
|
|
|
|
1,275,369
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
$
|
1,535,712
|
|
|
$
|
1,532,820
|
|
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
(in thousands, except share and per share data)
|
|
|
Three Months Ended March 31,
|
|
|
|
|
2023
|
|
|
2022
|
|
|
REVENUE:
|
|
|
|
|
|
|
|
Material sales
|
|
$
|
70,190
|
|
|
$
|
86,691
|
|
|
Royalty and license fees
|
|
|
55,210
|
|
|
|
59,802
|
|
|
Contract research services
|
|
|
5,067
|
|
|
|
3,977
|
|
|
Total revenue
|
|
|
130,467
|
|
|
|
150,470
|
|
|
COST OF SALES
|
|
|
32,970
|
|
|
|
33,163
|
|
|
Gross margin
|
|
|
97,497
|
|
|
|
117,307
|
|
|
OPERATING EXPENSES:
|
|
|
|
|
|
|
|
Research and development
|
|
|
31,423
|
|
|
|
26,545
|
|
|
Selling, general and administrative
|
|
|
15,396
|
|
|
|
21,062
|
|
|
Amortization of acquired technology and other intangible assets
|
|
|
2,891
|
|
|
|
5,498
|
|
|
Patent costs
|
|
|
2,255
|
|
|
|
1,798
|
|
|
Royalty and license expense
|
|
|
164
|
|
|
|
154
|
|
|
Total operating expenses
|
|
|
52,129
|
|
|
|
55,057
|
|
|
OPERATING INCOME
|
|
|
45,368
|
|
|
|
62,250
|
|
|
Interest income, net
|
|
|
6,967
|
|
|
|
291
|
|
|
Other loss, net
|
|
|
(703
|
)
|
|
|
(34
|
)
|
|
Interest and other loss, net
|
|
|
6,264
|
|
|
|
257
|
|
|
INCOME BEFORE INCOME TAXES
|
|
|
51,632
|
|
|
|
62,507
|
|
|
INCOME TAX EXPENSE
|
|
|
(11,793
|
)
|
|
|
(12,537
|
)
|
|
NET INCOME
|
|
$
|
39,839
|
|
|
$
|
49,970
|
|
|
NET INCOME PER COMMON SHARE:
|
|
|
|
|
|
|
|
BASIC
|
|
$
|
0.83
|
|
|
$
|
1.05
|
|
|
DILUTED
|
|
$
|
0.83
|
|
|
$
|
1.05
|
|
|
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET
INCOME PER COMMON SHARE:
|
|
|
|
|
|
|
|
BASIC
|
|
|
47,523,593
|
|
|
|
47,369,764
|
|
|
DILUTED
|
|
|
47,567,007
|
|
|
|
47,440,281
|
|
|
CASH DIVIDENDS DECLARED PER COMMON SHARE
|
|
$
|
0.35
|
|
|
$
|
0.30
|
|
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(in thousands)
|
|
|
Three Months Ended March 31,
|
|
|
|
|
2023
|
|
|
2022
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
Net income
|
|
$
|
39,839
|
|
|
$
|
49,970
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
Depreciation
|
|
|
6,496
|
|
|
|
5,627
|
|
|
Amortization of intangibles
|
|
|
2,891
|
|
|
|
5,498
|
|
|
Amortization of premium and discount on investments, net
|
|
|
(3,597
|
)
|
|
|
(271
|
)
|
|
Stock-based compensation to employees
|
|
|
3,992
|
|
|
|
6,085
|
|
|
Stock-based compensation to Board of Directors and Scientific Advisory Board
|
|
|
423
|
|
|
|
430
|
|
|
Deferred income tax benefit
|
|
|
(5,936
|
)
|
|
|
(1,380
|
)
|
|
Retirement plan expense, net of benefit payments
|
|
|
782
|
|
|
|
1,359
|
|
|
Decrease (increase) in assets:
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(13
|
)
|
|
|
2,692
|
|
|
Inventory
|
|
|
8,975
|
|
|
|
(9,080
|
)
|
|
Other current assets
|
|
|
8,598
|
|
|
|
(8,172
|
)
|
|
Other assets
|
|
|
5,515
|
|
|
|
9,488
|
|
|
Increase (decrease) in liabilities:
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
|
(24,116
|
)
|
|
|
(4,261
|
)
|
|
Other current liabilities
|
|
|
12,874
|
|
|
|
5,807
|
|
|
Deferred revenue
|
|
|
(8,616
|
)
|
|
|
(13,568
|
)
|
|
Other liabilities
|
|
|
(486
|
)
|
|
|
2,384
|
|
|
Net cash provided by operating activities
|
|
|
47,621
|
|
|
|
52,608
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(9,098
|
)
|
|
|
(10,751
|
)
|
|
Purchases of intangibles
|
|
|
(51
|
)
|
|
|
(12
|
)
|
|
Purchases of investments
|
|
|
(65,207
|
)
|
|
|
(24,915
|
)
|
|
Proceeds from sale and maturity of investments
|
|
|
115,031
|
|
|
|
50,240
|
|
|
Net cash provided by investing activities
|
|
|
40,675
|
|
|
|
14,562
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock
|
|
|
518
|
|
|
|
403
|
|
|
Payment of withholding taxes related to stock-based compensation to employees
|
|
|
(7,181
|
)
|
|
|
(7,896
|
)
|
|
Cash dividends paid
|
|
|
(16,769
|
)
|
|
|
(14,246
|
)
|
|
Net cash used in financing activities
|
|
|
(23,432
|
)
|
|
|
(21,739
|
)
|
|
INCREASE IN CASH AND CASH EQUIVALENTS
|
|
|
64,864
|
|
|
|
45,431
|
|
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
|
|
93,430
|
|
|
|
311,993
|
|
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
|
$
|
158,294
|
|
|
$
|
357,424
|
|
|
The following non-cash activities occurred:
|
|
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities
|
|
$
|
3,202
|
|
|
$
|
(5,031
|
)
|
|
Common stock issued to Board of Directors and Scientific Advisory Board that was
earned and accrued for in a previous period
|
|
|
300
|
|
|
|
300
|
|
|
Net change in accounts payable and accrued expenses related to purchases of property
and equipment
|
|
|
766
|
|
|
|
2,077
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230503006008/en/